Provided by Tiger Fintech (Singapore) Pte. Ltd.

GT Biopharma Inc.

2.84
+0.02000.71%
Post-market: 2.78-0.0600-2.11%19:52 EDT
Volume:67.89K
Turnover:195.51K
Market Cap:7.35M
PE:-0.41
High:3.01
Open:2.92
Low:2.75
Close:2.82
Loading ...
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 27, 2024

Correspondence

Form CORRESP - Correspondence
Jun 27, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 26, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2024

Major Issues Report

Form 8-K - Current report
Mar 26, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Dec 05, 2023

Major Issues Report

Form 8-K - Current report
Nov 01, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 23, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 05, 2023

Major Issues Report

Form 8-K - Current report